dailypolitical.com
Positivewww.dailypolitical.com ·
Insider Selling Mineralys Therapeutics Nasdaqmlys Insider Sells 6348 Shares of Stock
HealthDiseasesHealthcareTrade
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedInsider selling at Mineralys Therapeutics (NASDAQ:MLYS) is a company-specific event with no direct commercial mechanism affecting broader sectors or commodity prices. The stock decline reflects market perception of insider sentiment, but no supply, demand, or regulatory channel is triggered. Impact is limited to the single company's equity.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Insider David Malcom Rodman sold 6,348 shares at $29.36 on May 12, 2026.
- Rodman sold additional shares on May 13 (14,056 shares) and May 11 (2,171 shares).
- Stock price fell 8.2% to $26.86 on May 13.
- Market capitalization is $2.22 billion.
- Company focuses on hypertension and chronic kidney disease therapies.